Background
Introduction
The prevention of colorectal cancer could employ chemopreventive agents, but known agents afford only modest protection. We have previously established that a diet supplemented with an osmotic laxative suppresses an early putative step in the development of colon cancer in rats ( ), namely, the number of aberrant crypt foci (ACF) induced by an azoxymethane (AOM) injection ( ). The laxative was polyethylene 1 2 glycol 8000 (PEG), whose formula is H-(O-CH -CH ) -OH, with n 200. PEG and PEG-like block-polymer pluronic F68 are the most potent 2 2 n = known suppressors of ACF in rats ( , ). PEG also strikingly suppresses the occurrence of AOM-induced cancers in rats ( , ). This AOM-rat 3 4 5 6
model predicts the chemopreventive efficacy of dietary agents in humans ( ). Last, a population-based study shows that PEG-based laxative 7
users have a halved risk of colorectal tumors ( ). 8
The mechanism by which PEG suppresses ACF and cancer is not known. Fecal weight and moisture are more than doubled in PEG-treated rats ( ). Constipation, by contrast, is associated with increased risk of colon cancers in several case-control studies ( ). We thus looked for 1 [9] [10] [11] mechanism: PEG halts proliferation ( ), induces apoptosis ( ), and restores differentiation ( ) of adenocarcinoma cells in culture. We thus 17 18 19 sought a PEG effect on these functions in the colon of rats. A third hypothetical mechanism is that, like mucus, PEG might protect the mucosa ( ). Indeed, cell membrane can reseal after being damaged by mechanical stress in the gut ( ). Pluronic facilitates this repair process in vitro ( 20 21 ), We tested this hypothesis using fluorescein dextran ( ). 22 21
Materials and Methods

General Design and Initiation of Carcinogenesis
Seven sequential experiments were conducted in rats. Five 30-day studies tested the effect of laxative agents on AOM-induced ACF.
Another 30-day study tested the effect of PEG on cell proliferation and apoptosis. Unless otherwise stated we used PEG 8000. One 100-day study made use of a fluorescent marker to see whether PEG protects or kills crypt cells. A total number of 272 four-week old Fisher 344 rats were obtained from Iffa-Credo (Lyon, France). They were acclimatized to the animal colony for one week, housed by pairs in stainless steel wire drop-bottom cages, in a temperature of 22 2 C and with 12h/12h light and dark cycles. AIN76 diet from UAR (Villemoisson, France) ±°a nd tap water were provided Each rat was given one AOM i.p. injection to induce ACF (20 mg/kg in saline), and randomized 7 days ad libitum. later to receive treatment. All chemicals came from Sigma (St. Quentin, France), unless stated otherwise. Body weights, food and water intake were monitored weekly. Daily fecal output was measured on freeze-dried feces collected under each cage of two rats for 24 hours. Fecal humidity was measured on fresh pellets obtained directly at the anus of each rat (weighed before and after freeze-drying). Thirty and seven days (ACF studies), or 100 130 days (fluorescent marker study) after the AOM injection, the animals were sacrificed by carbon dioxide 
Studies of Laxative Agents
The effect of dietary laxative agents on AOM-induced ACF was compared to the standard AIN76 diet (control), in five 30-day studies.
They involved 32, 36 and 42 male, and 48 and 52 female rats (no gender effect was seen). In each study some rats were randomized to a control group, and to a group given dietary 5 (w/w) PEG 8000 (ICN, Orsay France). Laxative agents which were given to the other groups of rats as a substrate, and L-phenylalanine as a specific inhibitor of the intestinal isoenzyme. That PEG did not modify ALP values was specifically checked in vitro.
Study of PEG effect on Cell Proliferation and Apoptosis
Sixteen male rats received an AOM injection seven days before being randomized to a control group given pure water, and a treated group given 5 PEG in the drinking water for 30 days. Sixty minutes before sacrifice each rat received an i.p. injection of 5-bromo-2 -deoxyuridine % ′ (BrdU, 50 mg/kg in NaCl 9g/l). A 1 cm piece of distal colon was processed for histology after fixation in buffered formalin (10 ). 
Study of PEG Effect on Cell Resealing and Removal in Normal and Aberrant Crypts
Twelve rats received an AOM injection, ten rats did not. They were sacrificed 106 131 days after initiation. Fifty hours before sacrifice, -food was removed from cages. Thirty hours before sacrifice, all rats were given 250 mg fluorescein dextran by gavage (1 ml, MW 4400) ( ).
Eighteen hours before sacrifice ten rats were allowed to drink water with 5 PEG, and twelve rats were given pure water (see Table I were prepared as they had been for ACF. Fluorescein-labeled cells, and nuclei (to estimate total number of cells) were then counted in 100 normal and 60 aberrant crypts at 400 magnification with a fluorescence microscope (Axiolab, Zeiss).
×
Statistical Methods
Group means were compared by Student s test, or by Welch s test when variances were not equal, or by Mann-Whitney test when data ' t ' t were not normally distributed. To compare many treated groups to a single control group, the Dunnett s test was used when Bartlett s statistics ' ' showed non-significant differences among variances. A non-parametric Kruskal-Wallis was used in other cases. Standard deviations (SD) are reported in the text, and pooled standard error of the mean (SEM) in . All values quoted correspond to two-tailed test, and value Table I P P below 0.05 was considered significant.
Results
The Effect of 19 Laxative Agents on AOM-induced ACF, and on Fecal Values
Five independent short-term studies were conducted to test the hypothesis that laxative drugs can decrease the number of ACF during the post-initiation period. The results are shown on , using the ACF values in control rats to normalize data across the five studies (full data Figure 1 not shown). PEG, unique among laxative agents, strikingly suppressed ACF. Compared to control rats, PEG-treated rats had a nine-fold reduction in the number of ACF and a 13-fold reduction in the number of large ACF (mean of 5 studies, all p<0.001). Other PEGs also reduced the number of ACF, but to a lower extent. PEG 400 was roughly half as potent as PEG 8000, as previously shown for PEG 3350 ( ). Other 6 laxatives did not reduce significantly the number of ACF ( ) except magnesium hydroxide. In bisacodyl-fed rats all crypts looked Figure 1 aberrant and colons could not be scored for ACF, but small tumors were detected (N 0.8/rat). Rats treated with the non-laxative NSAID = piroxicam had significantly less ACF than controls (p<0.001), but twice more ACF than PEG-treated rats.
Laxative polymers of high MW, including PEGs, roughly doubled both the daily fecal output (dry weight) and the fecal moisture ( , Figure 2 full data not shown). The rats consumed and excreted about 1 g of PEG per day, which explains the increased fecal weight. Small MW agents had less effect on fecal values in rats, except magnesium hydroxide (doubled fecal moisture), kaolin and paraffin oil (doubled fecal dry weight).
Karaya gum, carboxymethylcellulose, polyvinylpyrrolidone and PEG were thus potent laxatives in rats (
), but only PEG 8000 strongly Figure 2 reduced the ACF number (
). This suggests that the ACF inhibition by PEG 8000 was not due solely to its fecal bulking activity. Figure 1 Indeed, a modest inverse correlation was found between the ACF number in the colon of rats and fecal dry weight and fecal moisture. The correlation coefficients were 0.40 and 0.53 respectively (p<0.05, d.f. 25). However, after exclusion of PEG data, the ACF number did not − − correlate any longer with fecal dry weight or with fecal moisture.
In vitro data suggest that cytostatic effect of PEG on cell lines be due to PEG-induced osmotic pressure ( ). Osmolarity of fecal water 17 from all rats was thus measured, but it was not changed by PEG or by laxative treatments (p>0.05), and it did not correlate with ACF numbers (data not shown). These results show that PEG-prevention of carcinogenesis is not due to laxative effect, or to osmotic properties of PEG.
PEG Increased Crypt Cells Apoptosis and Proliferation
Apoptosis, an important prevention mechanism ( ), was measured by two different techniques in 3 m sections of colonic mucosa from 25 PEG clearly enhanced apoptosis and epitheliolysis in the mucosa.
Crypt lengthening and cell proliferation are often associated with colon carcinogenesis ( ). We thus speculated that PEG-prevention might 27
be associated with crypt shortening and reduced cell proliferation. After a 30-day PEG-treatment in AOM-initiated rats, crypt height was reduced from 32.3 2.6 cells in controls to 27.3 2.9 in PEG-fed rats (p<0.01). But PEG surprisingly increased crypt cell proliferation. The 
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Fluorescein dextran labeled cells were easily counted on top of normal and aberrant crypts ( ). Twice more labeled cells were Figure 3 counted per AOM-initiated aberrant crypt cells, than per normal crypt cells ( , 12.5 and 5.4 cells respectively, p<0.001). According to Table I McNeil, this might suggest that transformed cells on top of ACF are more fragile, or more exposed to mechanical stress, than normal crypt cells 
Discussion
This study demonstrates that (i) among 19 laxatives, only PEG 8000 and its analogs were potent chemopreventive agents against colon carcinogenesis in a rat model, (ii) the mechanism of PEG protection was not related to increased fecal bulking or water content, (iii) PEG induced proliferation, epitheliosyis, and apoptosis in colonic crypts, which confirms Roy s findings ( ), and (iv) PEG seems to remove limited to a specific carcinogen, since hydrazine, nitrosamine, and heterocyclic amine-induced ACF are suppressed ( ). PEG effect is fast: a 6
three-day PEG-treatment, one month after carcinogen injection, halves the number of ACF in rats ( ). 6
The mechanism by which PEG can prevent carcinogenesis in rats is not known. Speculated mechanisms include (i) dilution of promoting compounds in the gut lumen due to PEG osmotic and bulking properties, (ii) protection of epithelia by PEG lubricating, coating, and sealing properties, (iii) elimination of cancer cells from the tumors by apoptosis induction. These three hypotheses are discussed here:
High-molecular weight PEGs are not absorbed from the gut of rats and bind water through hydrogen bonding ( ). In PEG-fed rats, the 29 fecal weight and moisture increased markedly ( ), and we have shown that the concentration of bile acids in fecal water is halved ( ). fig.2 1
However, the present study clearly shows that this bulking effect does not explain the anti-cancer properties of PEG. Indeed, some laxatives increased both fecal dry weight and fecal moisture as much as PEG, but they did not reduce ACF (e.g., karaya gum). Previous studies show that psyllium and wheat bran can double the fecal bulk, but only modestly suppress ACF ( ). Magnesium hydroxide also showed some protective 3 effect here. Magnesium is a known chemopreventive agent ( ). It may act like calcium, unrelated with laxative properties ( , ). Small 30-32 33 34 tumors were detected in bisacodyl-fed rats only one month after AOM injection, thus confirming it is a strong tumor promoter ( ). To 15 conclude, because bulking does not cause chemoprevention, it should be possible to design PEG-like chemopreventive agents with no laxative effect.
Alternatively, PEG may protect the colonic mucosa by lubricating the fecal stream ( ), by providing a mucin-like barrier and reducing 29 inflammation ( ), or by facilitating the membrane resealing ( ), thus reducing the ACF over-proliferation. This hypothesis is supported by 20 21 our in vitro data ( ) and by the strong chemoprevention afforded by pluronic ( ), a PEG-like agent that binds membranes and repairs cell 17 4 membrane defects ( ). In contrast, this study clearly shows that PEG increased proliferation, like aspirin and sulindac ( , ). PEG also 22 35 36 appears to increase the turn over of cells on top of ACF crypts ( ), and greatly increased fecal ALP, a potential marker of epitheliolysis (   -table I , ). In addition, while a 0.05 PEG concentration protects cells in vitro ( ), a 100-times higher concentration is needed to suppress ACF 23 24
Lastly, according to in vitro results, PEG might eliminate transformed cells by apoptosis ( , ). This would normalize or erase ACF, 17 18 " "
explaining the fast loss of ACF ( ). Indeed, PEG-treatment doubled the number of apoptotic bodies in colonic crypts, as recently reported in 6 ACF and in Min mice ( ). This could be meaningful because a fish oil and pectin diet that increases apoptotic index by 25 decreases 28 + % adenocarcinoma incidence by 50 in rats ( ). In addition PEG strikingly increased epitheliolysis in the gut, increased proliferation but − % 25 reduced crypt length, and halved the number of labeled cells on top of ACF ( ). Taken together, these facts suggest that PEG has an table I abrasive effect on the mucosa. How could abrasion be protective? Although it is highly controversial, the elimination of cells from the top of crypts might be enough to stop carcinogenesis, by preventing the top-down movement of transformed cells ( ). This would explain why theThe present study is not definitive, and following questions might still be addressed: (i) Do non-protective laxatives induce apoptosis and epitheliolysis? (ii) We suggest that PEG removes cells from ACF, that often hold K-mutation. The DNA of shedded cells can be detected in ras stools ( ). So, does PEG increase fecal flow of Kmutations? (iii) How could PEG induce apoptosis and epitheliolysis? Added into a 40 ras culture medium, PEG increases the osmotic pressure and shrinks cancer cells ( ). By contrast, in vivo, PEG drags water into the gut lumen, 17 which in turn balances the osmotic pressure ( ). Thus, PEG-effect is not due to osmotic pressure, but might be due to detergent properties. 29
Indeed, PEG induces cell fusion in vitro, accumulates in cancer cells, and the optimal MW to enhance endocytosis and to suppress ACF is identical, i.e., 8000 ( , ). Last, PEG-induced apoptosis may come from the modulation of transcription factors, e.g., induction of 6 41 pro-apoptotic factor Par-4, and suppression of E-cadherin down-regulating factor SNAIL ( , ). 18 42 To conclude, data suggest that PEG acts by eliminating cells from ACF. PEG is used as a mild laxative at a dose which matches the dose used in rats ( ). A recent population-based study of 1165 colonoscopies in France shows that Forlax users (a PEG 4000-based laxative) have 43 ® a halved risk of colorectal tumors ( ). High MW PEGs have no known toxicity, are not absorbed, not metabolized, and not fermented. We thus 8
suggest PEG be tested in a clinical trial.
Ackowledgements:
Studies were funded by Ligue-32, INRA and DGER, Ministry of Agriculture, France. 
Figure 2
High MW laxative agents increased the daily fecal excretion (dry weight) and the fecal moisture (percent water) in rats fed a purified diet for one 
Figure 3
Fluorescein dextran labeled cells on top of a four-crypt ACF Fluorescence micrograph of colon mucosa (magnification 400). The rat was sacrificed 130 d after an AOM injection, and 30 h after a 250 mg × fluorescein dextran gavage (this rat did not receive PEG). 
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